Daniel van Wamelen

Dr. Daniel van Wamelen is a Clinical Senior Lecturer in Neuroscience at King's College London, affiliated with the Department of Neuroimaging and School of Neuroscience within the Institute of Psychiatry, Psychology & Neuroscience. His research focuses on neurodegenerative diseases, particularly Huntington's and Parkinson's, utilizing neuroimaging techniques like MRI and PET to identify disease progression markers and treatment targets. He investigates non-motor symptoms, hypothalamic dysfunction, and circadian rhythm impacts in these conditions, collaborating with Prof. Ray Chaudhuri's Parkinson's research team. His work includes the iMarkHD study on Huntington's disease and studies on non-motor symptom scales in Parkinson's. He is also involved in post-COVID neurological research and clinical trial design for disease-modifying therapies.

• Education: PhD in Neuroscience (not detailed in provided text).

Research interests emphasize translational neuroimaging, clinical neurology, and circadian interventions. His studies span biomarker development, patient-centered outcome measures, and global health disparities in neurological research.

Key publications include work on hypothalamic neuropeptides in Huntington's, non-motor symptom validation scales, and circadian rhythm effects in Parkinson's. Collaborations extend to institutions like Radboud University Medical Centre and the Maurice Wohl Clinical Neuroscience Institute.